DataMeds AI, Inc. (MEDS)
0.9606
-0.21
(-17.90%)
USD |
NASDAQ |
Aug 28, 16:00
0.9702
+0.01
(+1.00%)
After-Hours: 20:00
DataMeds AI Shareholders Equity (Quarterly) : -19.50M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -19.50M |
| March 31, 2026 | -15.06M |
| December 31, 2025 | -12.45M |
| September 30, 2025 | 6.778M |
| June 30, 2025 | 0.9053M |
| March 31, 2025 | 4.479M |
| Date | Value |
|---|---|
| December 31, 2024 | 6.734M |
| September 30, 2024 | 9.985M |
| June 30, 2024 | -3.148M |
| March 31, 2024 | -2.974M |
| December 31, 2023 | -2.900M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Exlites Holdings International, Inc. | 0.3419M |
| Xcelerate, Inc. | -2.102M |
| PD-Rx Pharmaceuticals, Inc. | -- |
| Acro Biomedical Co. Ltd. | -0.4448M |
| Vivos Therapeutics, Inc. | -3.815M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 32.76M |
| Total Liabilities (Quarterly) | 52.26M |
| Debt to Equity Ratio | -1.681 |
| Current Ratio | 0.1429 |
| Net Debt Paydown Yield | -16.03% |